HTFL HTFL Regulatory And Clinical Expense
Regulatory And Clinical Expense at other companies
Other financials
Where this comes from
Reported directly by HTFL in its filing.
Tagged under the XBRL concept htfl:RegulatoryAndClinicalExpense.
The official record: HTFL’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about HTFL's regulatory and clinical expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is HTFL's regulatory and clinical expense?
- HTFL (HTFL) reported regulatory and clinical expense of $6.56M in Q4 2025.
- How has HTFL's regulatory and clinical expense changed year-over-year?
- HTFL's regulatory and clinical expense increased by 49.7% year-over-year, from $4.38M to $6.56M.
- What is the long-term trend for HTFL's regulatory and clinical expense?
- Over 2 years (2023 to 2025), HTFL's regulatory and clinical expense has grown at a 39.3% compound annual growth rate (CAGR), from $13.52M to $26.25M.
- What does regulatory and clinical expense mean?
- Captures the costs associated with clinical trials, regulatory filings, and compliance activities required to obtain and maintain product approvals. This metric is a critical measure of the investment required to navigate the legal and safety hurdles of the industry. It helps investors assess the progress and cost-intensity of the product development lifecycle.